A new Seizure paper published June 29 dug into 189 children with refractory epilepsy at Children’s Hospital of Fudan University to see whether early blood ketones, glucose and the glucose-ketone index, or GKI, could flag who would actually benefit from classic ketogenic diet therapy. The team followed those markers at multiple time points over the first two days, shifting the focus from simple carb counting to early metabolic response.
The cohort came from 236 children admitted between January 2018 and December 2024; 46 were excluded because of incomplete data or too short a treatment course, and one child died. That matters because classic ketogenic therapy is not casual diet advice. The International League Against Epilepsy defines drug-resistant epilepsy as failure to achieve sustained seizure freedom after two appropriately chosen, adequately administered, and well-tolerated antiseizure medications, and the International Ketogenic Diet Study Group says ketogenic diets should generally be used in children after two antiseizure drugs have failed, with some epilepsy syndromes warranting earlier use.
The treatment itself is old-school in the best sense. The classic ketogenic diet has been used continuously since 1921, and the Charlie Foundation, founded in 1994, along with Matthew’s Friends, founded in 2004, helped push ketogenic therapy into broader pediatric epilepsy awareness. The evidence base has stayed practical rather than theoretical: Cochrane found ketogenic diets favored seizure freedom and at least 50 percent seizure reduction in children compared with usual care, while a 2023 JAMA Pediatrics network meta-analysis found dietary therapies outperformed usual care for short-term seizure reduction, even as ketogenic and modified Atkins approaches carried higher adverse-event discontinuation rates.
That is why this paper’s biomarker angle stands out. Families and clinicians already know classic keto can work, but they also know it is demanding, slow to fine-tune and hard to keep going if seizure control lags. If early blood ketones, along with glucose and GKI shifts, help identify which children are on track, the diet becomes a more precise medical tool and less of a leap of faith. For refractory childhood epilepsy, that is the real payoff: figuring out sooner which children are most likely to respond to one of keto’s most established medical uses.
Every story on Keto Diet Magazine is assembled by an automated editorial system that works from verified research, official records, and credible reporting, then clears automated accuracy and moderation checks before it goes live. The standards that system follows are set and overseen by the people who run the publication. Read our full editorial policy.
Did this article answer your question?
